Michel Morichau-Beauchant
University of Poitiers
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michel Morichau-Beauchant.
Digestive Diseases and Sciences | 1992
Christine Silvain; Isabelle Besson; Pierre Ingrand; Philippe Beau; Eric Fort; Claude Matuchansky; Michel Carretier; Michel Morichau-Beauchant
The outcome of 31 patients with severe radiation enteritis treated by total parenteral nutrition (TPN) was analyzed. Before initiation of parenteral nutrition, 18 of the patients had not had abdominal surgery, while 13 had either a resection or an intestinal bypass for radiation enteritis. Median follow-up was 21/2 years (range: 1 month to 12 years) from the time of initiation of parenteral nutrition. Surgery was required in 15 cases because parenteral alimentation could not be continued. Only eight of these 15 were able to resume a normal oral intake. Total parenteral nutrition allowed oral feeding to be resumed in 11 (36%) after a median follow-up of 40 months (range: 6–142 months). In general, total parenteral nutrition was well tolerated and was associated with low morbidity. Eighteen patients died, 13 of complications due to radiation therapy, four of cancer recurrence, and one of an unrelated cause. Survival probability was 58% at one year and 36% at five years. When possible, prognostic factors present either before or at initiation of total parenteral nutrition were analyzed. Age, predisposing vascular factors (hypertension, diabetés mellitus, or vascular disease), and enteric fistula and/or perforation were found to have prognostic value. The probability of clinical radiation enteritis recurrence was 34% at one year and 47% at two years. A clinical recurrence of symptoms was more frequent but not significantly so after parenteral nutrition as compared to surgical therapy of radiation enteritis. Although TPN corrected denutrition and allowed deferred surgery in some patients, severe radiation enteritis remains a poorly predictable progressive disease with numerous relapses.
Surgical and Radiologic Anatomy | 1998
Jean-Pierre Richer; J. P. Faur; Michel Morichau-Beauchant; T. Dugue; Nicolas Maillot; P. Kamina; M. Carretier
We report, in an adult, an asymptomatic association between cystic dilatation of the bile duct (type IV A in Todani’s classification) and anomalous pancreatico-biliary ductal union (APBD) with stones in a long common channel. In APBD, the connection between the common bile duct and the main pancreatic duct is located outside the duodenal wall and is therefore not under the influence of the sphincter of Boyden. An abnormally long common channel is in excess of 15 mm. Two types of convergence anomalies are defined according to whether the bile duct opens into the main pancreatic duct (BP) or the main pancreatic duct into the bile duct (PB). In APBD, there is probably a reverse pressure gradient between the bile and pancreatic ducts, with regurgitation of pancreatic juice into the bile duct, repeated attacks of cholangitis, stenosis and cystic dilatation. A long common channel is associated with a higher incidence of carcinoma of the gall bladder or the bile duct.
Gastroenterology | 1981
Claude Matuchansky; Michel Morichau-Beauchant; François Druart; Jeanine Tapin
Archive | 1981
Claude Matuchansky; Michel Morichau-Beauchant; François Druart; Jeanine Tapin
Gastroenterology | 1980
Claude Matuchansky; Michel Morichau-Beauchant; Guy Touchard; Lenormand Y; Bloch P; Tanzer J; Dominique Alcalay; Philippe Babin
Gastroenterology | 1982
Michel Morichau-Beauchant; Guy Touchard; Philippe Maire; Michel Briaud; Philippe Babin; Dominique Alcalay; Claude Matuchansky
Gastroenterologie Clinique Et Biologique | 1998
V. de Ledinghen; Philippe Beau; P.-R. Mannant; Marie Pierre Ripault; Catherine Borderie; C. Silvain; Michel Morichau-Beauchant
Gastroenterologie Clinique Et Biologique | 1994
V. de Ledinghen; P. Levillain; I. Besson; L. Palazzo; M. Fabre; C. Silvain; Michel Morichau-Beauchant
The Lancet | 1981
Michel Briaud; Michel Morichau-Beauchant; Claude Matuchansky; Guy Touchard; Philippe Babin
Hépato-Gastro & Oncologie Digestive | 1995
Thierry Barrioz; Isabelle Besson; Philippe Beau; Michel Morichau-Beauchant